98%
921
2 minutes
20
Background: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary disease caused by NOTCH3 mutation. Nailfold capillaroscopy is a non-invasive technique typically used for rheumatic diseases. It has potential in other conditions linked to vascular pathology. However, capillaroscopy in CADASIL has not been explored. This study aims to investigate whether capillaroscopy measurements can correlate with brain vascular changes in preclinical CADASIL patients, specifically those with NOTCH3 mutation.
Methods: This study included 69 participants from the Taiwan Precision Medicine Initiative (TPMI) dataset who visited Taichung Veterans General Hospital from January to December 2022. All individuals underwent genetic studies, brain imaging and nailfold capillaroscopy. The Mann-Whitney U test was used to compare results of brain imaging between carriers and controls. It was also used to compare measurements in nailfold capillaroscopy within each group. Spearman Rank Correlation Analysis was used to explore the relationship between capillary measurements and brain MRI results.
Results: White matter hyperintensities (WMH) expression was positively correlated with capillary dimension and negatively correlated with density. Our results presented that R544C carriers exhibited a diffuse increase in WMH (p < 0.001) and a global reduction in gray matter volume but preserved in specific areas. The white matter lesion scores in all brain regions were higher in the mutation carriers than the controls. (p < 0.001).
Conclusion: This research highlights the association of nailfold capillaroscopy findings with white matter lesions in preclinical CADASIL patients. Capillaroscopy guides an effective screening strategy in individuals with NOTCH3 mutations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jns.2024.123109 | DOI Listing |
Ann Med Surg (Lond)
September 2025
HAMS Hospital Pvt. Ltd., Kathmandu, Nepal.
Background: In clinical practice, some cases gently challenge our assumptions, reminding us that not everything is what it seems. This is the story of a young woman receiving treatment for tuberculosis who began showing signs that pointed beyond infection alone. It underlines how autoimmunity can surface in the shadows of another illness, demanding careful attention and an open mind.
View Article and Find Full Text PDFIntern Med J
September 2025
Rheumatology Department of Lucania - UOSD of Rheumatology, "Madonna delle Grazie" Hospital, Matera, Italy.
Mod Rheumatol
August 2025
Division of Pediatric Rheumatology, Department of Pediatrics, Istanbul University Faculty of Medicine, Istanbul, Türkiye.
Objectives: Juvenile psoriatic arthritis (JPsA), a subtype of juvenile idiopathic arthritis, is a chronic inflammatory disease characterized by joint and skin involvement. Microvascular alterations, including endothelial dysfunction and inflammation, are thought to contribute to its pathophysiology. Nailfold videocapillaroscopy (NVC) is a non-invasive technique for assessing microvascular changes.
View Article and Find Full Text PDFCurr Rheumatol Rev
August 2025
Sivas Cumhuriyet University Faculty of Medicine, Sivas, Turkey.
Introduction: Systemic sclerosis is a complex autoimmune disease characterized by diverse clinical manifestations that vary among individuals. It is associated with significant morbidity and mortality. This study aimed to evaluate the existing literature on the use of capillaroscopy in systemic sclerosis and to perform a bibliometric analysis.
View Article and Find Full Text PDFRheumatol Int
August 2025
Department of Rheumatology of Lucania - UOSD of Rheumatology, "Madonna delle Grazie" Hospital, Matera, Italy.
Nailfold videocapillaroscopy typically shows a gradual progression through early, active, and late scleroderma patterns over years in systemic sclerosis. Rapid evolution directly to active pattern within months of Raynaud's phenomenon onset is rarely documented. We report a 39-year-old non-smoking Caucasian woman who developed Raynaud's phenomenon in April 2025.
View Article and Find Full Text PDF